Skip to main navigation Skip to search Skip to main content

A Multi-Center, Randomized, Double-Blind, Active-Controlled, Parallelgroup Phase 3 Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Ramipril on Morbidity and Mortality in High Risk Patients Following an Acute Myocardial...

Project: Research

Project Details

StatusFinished
Effective start/end date03/14/1707/13/19

Funding

  • Novartis Pharmaceuticals Corporation: $10,600.00